ADVM - Adverum Biotechnologies, Inc.
4.36
0.100 2.294%
Share volume: 1,023,039
Last Updated: 12-08-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$4.26
0.10
0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-09-2024 | 08-12-2024 | 11-04-2024 | 05-14-2025 | 08-12-2025 | 11-12-2025 | |
| Cash flow financing | 119.880 M | -116.000 K | 0.000 | 0.000 | 120.000 K | 9.899 M | |
| Other financing cash flows | 139.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | 74.608 M | -22.287 M | 0.000 | -11.491 M | -6.743 M | -16.358 M | |
| Net income | -24.787 M | -18.476 M | -27.134 M | -47.019 M | -49.191 M | -47.652 M | |
| Depreciation | 997.000 K | 956.000 K | 890.000 K | 683.000 K | 535.000 K | 465.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -22.027 M | -2.327 M | -13.346 M | 31.280 M | 31.904 M | 1.858 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 90.000 K | 16.000 K | 221.000 K | 220.000 K | 120.000 K | 142.000 K | |
| Cash Change | 74.608 M | -22.287 M | -34.470 M | -11.491 M | -6.743 M | -16.358 M |